Associate Professor of Medicine (Endocrinology); Director, Yale Obesity Research Center (Y-Weight)
Field:
Expertise:
Obesity, diabetes, pediatrics,
Description:
Dr. Jastreboff’s research includes large, multi-center clinical outcomes trials using novel anti-obesity pharmacotherapeutics and studies examining the neurobiology underlying obesity and mechanisms of anti-obesity medications, including dual hormone receptor agonist tirzepatide and triple hormone receptor agonist retatrutide (NEJM) a novel GIP/GLP-1/Glucagon receptor agonist.